Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0090-2746 in Type 2 Diabetes
NCT02205528Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2014
- Primary completion
- Sep 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NNC0090-2746 in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2014; status: completed.
02
Drugs
NNC0090-2746
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02205528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205528.